Cyclerion Therapeutics Inc.
CYCN | NASDAQ
$23.52
$0.00 (0.00%)
Nov 2, 2026, 11:20 AM ET · Market open
Market Data
Market Cap $15.73M
Enterprise Value $14.34M
Beta 1.75
Average Volume N/A
Shares Outstanding (Diluted) 607.29K
Shares Change YoY 38.42%
Institutional Ownership N/A
Exchange NASDAQ
ISIN N/A
Price Performance
Price Change 1M -30.8%
Price Change 3M -4.0%
Price Change 6M 1.5%
Price Change YTD 164.6%
Price Change 1Y 70.6%
Price Change 3Y 29.2%
Price Change 5Y -93.4%
1M CAGR (ann.) 12.8%
1Y CAGR (ann.) 77.0%
5Y CAGR (ann.) -41.1%
All-Time CAGR -41.4%
Valuation
PE Ratio -1.95
Forward PE N/A
PEG Ratio 0.03
Forward PEG 0.19
PS Ratio 8.28
Forward PS 26.80
PB Ratio 3.09
P/FCF Ratio -3.53
P/Adj. FCF Ratio -3.36
P/OCF Ratio -3.21
EV/Sales 7.55
EV/EBIT -2.14
EV/EBITDA -2.14
EV/FCF -3.22
Earnings Yield -51.2%
FCF Yield -28.3%
Adj. FCF Yield -29.7%
Financial Health
Net Cash $1.39M
Total Debt $0
Cash & Short-Term Investments $1.39M
Total Assets $6.93M
Current Ratio 0.82
Quick Ratio 0.82
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -53.60
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 61.6%
Operating Profit Margin -359.2%
EBITDA Margin -353.0%
Net Profit Margin -353.0%
FCF Margin -234.3%
Adj. FCF Margin -246.2%
SBC / Revenue 11.9%
SBC Impact (per share) -5.1%
Returns
Return on Assets -96.8%
Return on Equity -88.0%
Return on Invested Capital -134.2%
Return on Capital Employed -134.2%
Return on Tangible Assets -96.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 70.0%
Revenue CAGR 5Y -12.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 68.0%
EPS CAGR 5Y 62.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y 56.1%
FCF CAGR 5Y 55.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating N/A
Analyst Count N/A
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$50.40
EPS Growth Est (next Q) 16700.0%
Revenue Est (next Q) $550K
Revenue Growth Est (next Q) -37.1%
Cash Flow
Operating Cash Flow $-4.45M
Free Cash Flow $-4.45M
Adj. Free Cash Flow $-4.68M
FCF Per Share -$7.33
OCF Per Share -$7.33
OCF/S Ratio -234.3%
Income Statement
Revenue $1.9M
Gross Profit $1.17M
Operating Income $-6.82M
EBITDA $-6.71M
Net Income $-6.71M
EPS (Diluted) -$12.04
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove CYCN